ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

Chinese court rules in Novozymes’ favor

by Jean-François Tremblay
February 27, 2017 | APPEARED IN VOLUME 95, ISSUE 9

The Supreme People’s Court of China has ruled against two Chinese companies accused of infringing Novozymes’ patent on a glucoamylase enzyme used to make fuel and beverage ethanol. Shandong Longda Bio-Products and Jiangsu Boli Bioproducts had initially been found in violation of the Novozymes patent by a lower court in 2011, but the companies appealed, arguing against the patent’s validity. Novozymes says the legal win will encourage further development of the Chinese biotechnology industry.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment